RESEARCHER PROFILE

М. А. Никитина

← Back to Siberian State Medical University

М

Siberian State Medical University

Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsNuclear Receptors and SignalingGut microbiota and healthEpilepsy research and treatment

М. А. Никитина works in Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Nuclear Receptors and Signaling, Gut microbiota and health, Epilepsy research and treatment. Recorded institutional associations include Siberian State Medical University, Ministry of Health of the Russian Federation.

56Publications
569Citations
5H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Analysis of Gut Microbiota in Patients with Parkinson’s Disease

    2017 · 485 citations
  2. Comparison study of gut microbiota in case of Parkinson’s disease and other neurological disorders

    2016 · 17 citations
  3. Methods for evaluating of olfactory function in patients with Parkinson’s disease

    2015 · 8 citations
  4. [Correlation Between Emotional-Affective Disorders and Gut Microbiota Composition in Patients with Parkinson’s Disease].

    2017 · 6 citations
  5. Is gut microbiota associated with Parkinson’s disease?

    2016 · 5 citations
  6. Depression and other nonmotor manifestations of Parkinson’s disease

    2017 · 5 citations
  7. The relationship between the rs6265 polymorphism of the BDNF gene and the level of serum neurotrophic factor in patients with Parkinson’s disease

    2024 · 5 citations
  8. Olfactory dysfunction and modification in microbiota as early non-motor manifestations of Parkinson’s disease

    2016 · 4 citations
  9. Atypical course of Parkinson’s disease with clinical manifestations of Huntington’s disease in a patient with an allele of 27 CAG repeats in the HTT gene

    2021 · 4 citations
  10. Associations of serum neuromarkers with clinical features of Parkinson’s disease

    2024 · 4 citations
  11. Association of inflammation and chronic fatigue syndrome in patients with Parkinson’s disease

    2024 · 4 citations
  12. The heterogeneity of non-motor symptoms in patients with Parkinson's disease in Tomsk region

    2019 · 3 citations
  13. USING BIOFEEDBACK FOR REHABILITATION OF PATIENTS WITH PARKINSON'S DESEASE

    2014 · 2 citations
  14. A role of the gastrointestinal tract microbiota in the pathogenesis of Parkinson’s disease

    2016 · 2 citations
  15. CLINICAL LATERALIZING SIGNS IN SYMPTOMATIC TEMPORAL LOBE EPILEPSY

    2015 · 2 citations
  16. Markers of Neurodegeneration in Parkinson’s Disease

    2023 · 2 citations
  17. The association of single-nucleotide polymorphism rs6265 of the brain-derived neurotrophic factor gene with clinical features in Parkinson’s disease

    2024 · 2 citations
  18. Behavioral impairment in Parkinson's Disease in the Siberian region

    2013 · 1 citations
  19. THE IMPORTANCE OF ELECTROENCEPHALOGRAPHIC ACTIVATING METHODS IN CLINICAL PRACTICE OF NEUROLOGIST

    2015 · 1 citations
  20. PHELAN–MCDERMID SYNDROM (del 22q13 AND r(22)): LITERATURE REVIEW AND 2 CASE REPORTS

    2017 · 1 citations
  21. THE IMPORTANCE OF ELECTROENCEPHALOGRAPHIC ACTIVATING METHODS IN CLINICAL PRACTICE OF NEUROLOGIST

    2013 · 1 citations
  22. Feature olfactory dysfunction and gut microbiota in Parkinson's disease

    2017 · 1 citations
  23. Serum S100Β protein and Glasgow Coma Scale as predictive markers of the survival rate in acute ischemic stroke

    2021 · 1 citations
  24. The role of repair genes in the pathogenesis of Parkinson's disease

    2021 · 1 citations
  25. Environmental and genetic risk factors for Parkinson’s disease

    2023 · 1 citations

← Return to the university profile